Advertisement
Screener

Carlsmed, Inc. (CARL) Payments to Acquire Marketable Securities

1.4 / 5 stars · 2/7 Roast Me

Carlsmed, Inc. Payments to Acquire Marketable Securities

Carlsmed, Inc. (CARL) reported Payments to Acquire Marketable Securities of $18.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-05

  • 2026-06-30: Payments to Acquire Marketable Securities 6 month $18.91M.
  • 2025-06-30: Payments to Acquire Marketable Securities 6 month $0.00.
Period endPayments to Acquire Marketable Securities 6 month
2026-06-30$18.91M
10-Q · filed 2026-08-05
2025-06-30$0.00
10-Q · filed 2026-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orthofix Medical Inc. (OFIX)$0.373B
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
Embecta Corp. (EMBC)United States$0.319B2.10
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16